International Journal of
Reproductive Biomedicine
Tue, May 14, 2024
[Archive]
Volume 11, Issue 6 (9-2013)
IJRM 2013, 11(6): 453-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zaimy M A, Kalantar S M, Sheikhha M H, Jahaninejad T, Pashaiefar H, Ghasemzadeh J et al . The frequency of Yq microdeletion in azoospermic and oligospermic Iranian infertile men. IJRM 2013; 11 (6) :453-0
URL: http://ijrm.ir/article-1-428-en.html
URL: http://ijrm.ir/article-1-428-en.html
Mohammad Ali Zaimy1 
, Seyyed Mehdi Kalantar * 2, Mohammad Hasan Sheikhha1 , Tahere Jahaninejad3 , Hossein Pashaiefar3 , Jalal Ghasemzadeh1 , Mahnaz Zahraei3
, Seyyed Mehdi Kalantar * 2, Mohammad Hasan Sheikhha1 , Tahere Jahaninejad3 , Hossein Pashaiefar3 , Jalal Ghasemzadeh1 , Mahnaz Zahraei3
1- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , smkalantar@yahoo.com
3- Department of Genetics, Faculty of Medical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , smkalantar@yahoo.com
3- Department of Genetics, Faculty of Medical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Full-Text [PDF 284 kb]
(516 Downloads)
| Abstract (HTML) (2917 Views)
Full-Text: (594 Views)
Introduction
Infertility is the inability to conceive after one year of unprotected intercourse (1). Infertility affects approximately 10-15% of all married couples attempting pregnancy in the general population, and today it is a major public health problem. Male factor is responsible for 40% of the cases approximately and in 20% of cases both man and woman are affected (2, 3). Male infertility can be caused by many different factors, such as infection, varicose, endocrine disorders, spermatic duct obstruction, anti-sperm antibodies, systemic diseases, testicular cancer, testicular trauma, malnutrition, genetic defects and environmental conditions (2, 4, 5). It is estimated that 40-50% of these men have quantitative or qualitative abnormality in their sperm production. In more than 60% of these cases the origin of testicular dysfunction is unknown (6). It has been shown that the Y chromosome is involved in spermatogenesis. Since 1976 it was established that some deletions in long arm of Y chromosome is associated with sperm production failure (7).
In the last few years, using molecular methods, the loci involved in production and differentiation of sperms have been identified. Male-related genes such as sex-determining region of Y-chromosome (SRY) and several other spermatogenesis-related genes are accumulated in Y chromosome (8). The Y chromosome has been subdivided into 7 deletion intervals, each of these intervals consists of subintervals (A, B, C, etc.) (9)
In 1992, Vollrath et al constructed a map of Y chromosome with 43 interval deletions that consist of a region of sequence tagged sites (STS) which span to the both arms of Y chromosome. Critical genes for spermatogenesis are located in deletion interval 6 and deletion interval 5 also on long arm of Y chromosome.
Deletion in the azoospermia factor (AZF), region is associated with azoospermia and oligospermia. The AZF region has at least 3 loci-AZFa, AZFb, and AZFc which are required for normal spermatogenesis (3). In some text a fourth region has been suggested to be existing between AZFb and AZFc region, and is termed as AZFd (10).
DFFRY and DBY are two main genes in AZFa region. RBMY, PRY, and CDY2 are protein-encoding genes families on the AZFb region that are expressed in the testis only. BPY2, CDY, DAZ, CSPG4LY, GOLGAZLY are genes on AZFc region which are expressed only in testis. This region also has some genes that they have not testis specific expression (11, 12).
Using assisted reproductive technologies (ART) such as in vitro fertilization (IVF) and intra cytoplasmic sperm injection (ICSI) for treatment of male infertility may result in the passing of Y chromosome microdeletions to the sons, resulting in the persistence of infertility problem over the next generations (13-15).
In this study we evaluated the frequency of AZF deletions among Iranian azoospermic and oligospermic infertile men using multiplex polymerase chain reaction (M-PCR) method.
Materials and methods
This research was a case control study, which was carried out in Yazd Research and Clinical Center for Infertility in 2012. In total 49 infertile men were randomly selected from couple attending to Yazd Research and Clinical Center for Infertility as case group. Inclusion criteria were azoospermic or oligospermic men with no anatomical or syndromic abnormalities. According to WHO criteria, men that their sperm count was less than 2x106/ml were grouped as oligoosperms. For control group, 50 normozospermic men were selected according to semen analysis which was performed according to WHO normal standard parameters.
Exclusion criteria were men with anatomical or syndromic abnormalities. Informed consent was taken from all patients. This study was confirmed by ethical board of Yazd Research and Clinical Center for Infertility. Financial support was provided by Yazd Research and Clinical Center for Infertility.
Molecular analysis
Genomic DNA was extracted from leukocytes of peripheral blood by salting out method (16). According to the European Academy of Andrology (EAA), the European Molecular Genetics Quality Network (EMQN), and previous studies that were done in Iran, we selected a series of 13 sequence tagged sites (STSs) markers (17, 18). The STS markers were sY182 for AZFa, sY133 for AZFb, sY255, sY254, sY146, sY158, sY238, sY155, sY277, sY272, sY283, sY157 for AZFc and sY153 for AZFd. Because of high incidence of Y chromosome microdeletion in AZFc region we selected 10 STS in this region to find the best and the most informative STSs groups for screening of this region.
The sequence of primers is shown in table I. Seven set of multiplexes were designed as follows:
PCR 5X reaction buffer: 2.5µl (Faza pajouh Iran)
dNTPs mixture: 1.0µl (Faza pajouh Iran)
MgCl2:1.3µl (Faza pajouh Iran)
Primers 2-4 µl (Faza pajouh Iran)
H2O:14.8 µl
Taq DNA polymerase: 0.7µl (Faza pajouh Iran)
Genomic DNA sample: 0.7µl.
In this study we used two thermal programs, one as normal PCR:
1/ 95oC, 60s
2/ 95, 30s, 56oC, 30s, 72oC, 30s for 23 cycles
3/ 72oC, 60s
In some reactions we use touchdown thermal PCR program in that the first annealing temperature was 63oC and the final annealing temperature was 57oC in 17-19
Table I. STSs name and their primer sequences
91-61-4/Table_1.jpg)
Table II. Some features of 4 patients with Y chromosome microdeletions
91-61-4/Table_2.jpg)
91-61-4/Figure_1.jpg)
Figure 1. Results from multiplex polymerase chain reaction analysis.
lane 1 shows 100bp DNA marker. lane 2 shows normal woman.
lane 3 shows a normal man. lane 4 shows patient with deletion in sY255.
lane 5 shows patient with no deletion. lane 6 shows patient with deletion in sY133.
Table III. Percentage of Yq microdeletion in different study
91-61-4/Table_3.jpg)
Conflict of interest
The authors declare that there is no conflidt of interest.
Infertility is the inability to conceive after one year of unprotected intercourse (1). Infertility affects approximately 10-15% of all married couples attempting pregnancy in the general population, and today it is a major public health problem. Male factor is responsible for 40% of the cases approximately and in 20% of cases both man and woman are affected (2, 3). Male infertility can be caused by many different factors, such as infection, varicose, endocrine disorders, spermatic duct obstruction, anti-sperm antibodies, systemic diseases, testicular cancer, testicular trauma, malnutrition, genetic defects and environmental conditions (2, 4, 5). It is estimated that 40-50% of these men have quantitative or qualitative abnormality in their sperm production. In more than 60% of these cases the origin of testicular dysfunction is unknown (6). It has been shown that the Y chromosome is involved in spermatogenesis. Since 1976 it was established that some deletions in long arm of Y chromosome is associated with sperm production failure (7).
In the last few years, using molecular methods, the loci involved in production and differentiation of sperms have been identified. Male-related genes such as sex-determining region of Y-chromosome (SRY) and several other spermatogenesis-related genes are accumulated in Y chromosome (8). The Y chromosome has been subdivided into 7 deletion intervals, each of these intervals consists of subintervals (A, B, C, etc.) (9)
In 1992, Vollrath et al constructed a map of Y chromosome with 43 interval deletions that consist of a region of sequence tagged sites (STS) which span to the both arms of Y chromosome. Critical genes for spermatogenesis are located in deletion interval 6 and deletion interval 5 also on long arm of Y chromosome.
Deletion in the azoospermia factor (AZF), region is associated with azoospermia and oligospermia. The AZF region has at least 3 loci-AZFa, AZFb, and AZFc which are required for normal spermatogenesis (3). In some text a fourth region has been suggested to be existing between AZFb and AZFc region, and is termed as AZFd (10).
DFFRY and DBY are two main genes in AZFa region. RBMY, PRY, and CDY2 are protein-encoding genes families on the AZFb region that are expressed in the testis only. BPY2, CDY, DAZ, CSPG4LY, GOLGAZLY are genes on AZFc region which are expressed only in testis. This region also has some genes that they have not testis specific expression (11, 12).
Using assisted reproductive technologies (ART) such as in vitro fertilization (IVF) and intra cytoplasmic sperm injection (ICSI) for treatment of male infertility may result in the passing of Y chromosome microdeletions to the sons, resulting in the persistence of infertility problem over the next generations (13-15).
In this study we evaluated the frequency of AZF deletions among Iranian azoospermic and oligospermic infertile men using multiplex polymerase chain reaction (M-PCR) method.
Materials and methods
This research was a case control study, which was carried out in Yazd Research and Clinical Center for Infertility in 2012. In total 49 infertile men were randomly selected from couple attending to Yazd Research and Clinical Center for Infertility as case group. Inclusion criteria were azoospermic or oligospermic men with no anatomical or syndromic abnormalities. According to WHO criteria, men that their sperm count was less than 2x106/ml were grouped as oligoosperms. For control group, 50 normozospermic men were selected according to semen analysis which was performed according to WHO normal standard parameters.
Exclusion criteria were men with anatomical or syndromic abnormalities. Informed consent was taken from all patients. This study was confirmed by ethical board of Yazd Research and Clinical Center for Infertility. Financial support was provided by Yazd Research and Clinical Center for Infertility.
Molecular analysis
Genomic DNA was extracted from leukocytes of peripheral blood by salting out method (16). According to the European Academy of Andrology (EAA), the European Molecular Genetics Quality Network (EMQN), and previous studies that were done in Iran, we selected a series of 13 sequence tagged sites (STSs) markers (17, 18). The STS markers were sY182 for AZFa, sY133 for AZFb, sY255, sY254, sY146, sY158, sY238, sY155, sY277, sY272, sY283, sY157 for AZFc and sY153 for AZFd. Because of high incidence of Y chromosome microdeletion in AZFc region we selected 10 STS in this region to find the best and the most informative STSs groups for screening of this region.
The sequence of primers is shown in table I. Seven set of multiplexes were designed as follows:
- Multiplex 1: sY238, sY153
- Multiplex 2: sY133, sY255, sY272
- Multiplex 3: sY283, sY146
- Multiplex 4: sY155, sY158
- Multiplex 5: sY254, sY182
- Multiplex 6: sY157, sY182
- Multiplex 7: sY277, sY182.
PCR 5X reaction buffer: 2.5µl (Faza pajouh Iran)
dNTPs mixture: 1.0µl (Faza pajouh Iran)
MgCl2:1.3µl (Faza pajouh Iran)
Primers 2-4 µl (Faza pajouh Iran)
H2O:14.8 µl
Taq DNA polymerase: 0.7µl (Faza pajouh Iran)
Genomic DNA sample: 0.7µl.
In this study we used two thermal programs, one as normal PCR:
1/ 95oC, 60s
2/ 95, 30s, 56oC, 30s, 72oC, 30s for 23 cycles
3/ 72oC, 60s
In some reactions we use touchdown thermal PCR program in that the first annealing temperature was 63oC and the final annealing temperature was 57oC in 17-19
cycles. The annealing temperature in different reaction according to primers Tm could be changed.
Statistical analysis
X2 test was done to compare differences between the case and control group. The statistical analysis was performed with SPSS 16 statistical software. The p-value under 0.05 was considered as significant difference.
Results
As described in methods, a total of 50 infertile men were selected in this study, 16 (16/50=32%) of whom were azoospermic males and 34 (34/50=68%) were oligospermic men.
The total percentage of microdeletions detected in case group was 8% (4/50). AZFc was the most deleted region (4/5=80% of deletions) that followed by AZFb (1/5=20% of deletions), AZFa and AZFb have no deletions. No men in control group show microdeletion in Yq chromosome. The percentage of Y chromosome microdeletion in azoospermic men was higher than this percentage in oligospermics [19% (3/16) among azoospermic men and 3% (1/34) among oligospermics]. Serum FSH level in men with microdeletions was higher than men that have no deletions (p=0.034).
There was not a significant difference between men with Y chromosome microdeletions and men no deletions age (p=0.60).
Statistical analysis
X2 test was done to compare differences between the case and control group. The statistical analysis was performed with SPSS 16 statistical software. The p-value under 0.05 was considered as significant difference.
Results
As described in methods, a total of 50 infertile men were selected in this study, 16 (16/50=32%) of whom were azoospermic males and 34 (34/50=68%) were oligospermic men.
The total percentage of microdeletions detected in case group was 8% (4/50). AZFc was the most deleted region (4/5=80% of deletions) that followed by AZFb (1/5=20% of deletions), AZFa and AZFb have no deletions. No men in control group show microdeletion in Yq chromosome. The percentage of Y chromosome microdeletion in azoospermic men was higher than this percentage in oligospermics [19% (3/16) among azoospermic men and 3% (1/34) among oligospermics]. Serum FSH level in men with microdeletions was higher than men that have no deletions (p=0.034).
There was not a significant difference between men with Y chromosome microdeletions and men no deletions age (p=0.60).
Table I. STSs name and their primer sequences
Table II. Some features of 4 patients with Y chromosome microdeletions
Figure 1. Results from multiplex polymerase chain reaction analysis.
lane 1 shows 100bp DNA marker. lane 2 shows normal woman.
lane 3 shows a normal man. lane 4 shows patient with deletion in sY255.
lane 5 shows patient with no deletion. lane 6 shows patient with deletion in sY133.
Discussion
Deletions of AZF regions are deletions of the euchromatin part of the Yq chromosome. It is thought that these deletions of Y chromosome can damage genes in this region that are responsible for the proper course of spermatogenesis. Many factors such as somatic and sex chromosome genes interactions are candidate to have role in the normal spermatogenesis. The AZF deletions are the most frequent cause of spermatogenetic failure (8). After Klinefelter’s syndrome, Yq microdeletions are the second most frequent and important spermatogenesis genetic disorder in male infertility. Previous studies have reported that Yq microdeletions changed from 1-55% between infertile men, but most studies have revealed this ratio below 15% (19).
In our study the frequency of microdeletion in azoospermic and oligospermic men was 19% among azoospermic men and 3% among oligospermic men that is similar to the range of the published data (20). Some studies that were done in Iran have reported different results from our study. Omrani et al showed that the incidence of microdeletions among azoospermic patients in North West of Iran was 24.2%; Malekasgar et al indicated that the incidence of Yq microdeletions in South West of Iran was higher than international frequency. They found microdeletions in 52% (16, 21).
These variations in frequencies could be due to different origins of the studied population and differences in the study design including the composition of the study population and different STSs selection. Mirfakhraie et al showed that the incidence of microdeletion in Yq chromosome is 12% that this result is similar to ours (17). In table III we compared our results with other similar studies. With use of mentioned STSs we reported the most frequent microdeletions in AZFc, followed by AZFb and no deletion in AZFa and AZFd that is similar to many past studies such as Mirfakhraie et al who reported the most frequent microdeletions in AZFb region followed by AZFc.
Controversy in Y chromosomal microdeletions of infertile men arises from this fact that Yq microdeletions will be transmitted by ICSI and cause the infertility problem in sons. This possibility has been described previously (22). Screening of Yq microdeletions can help medical stuff to give informative counseling to couples with these deletions that want to use Because of this probability ethical consequences should be one of the important dimensions of these techniques.
Deletions of AZF regions are deletions of the euchromatin part of the Yq chromosome. It is thought that these deletions of Y chromosome can damage genes in this region that are responsible for the proper course of spermatogenesis. Many factors such as somatic and sex chromosome genes interactions are candidate to have role in the normal spermatogenesis. The AZF deletions are the most frequent cause of spermatogenetic failure (8). After Klinefelter’s syndrome, Yq microdeletions are the second most frequent and important spermatogenesis genetic disorder in male infertility. Previous studies have reported that Yq microdeletions changed from 1-55% between infertile men, but most studies have revealed this ratio below 15% (19).
In our study the frequency of microdeletion in azoospermic and oligospermic men was 19% among azoospermic men and 3% among oligospermic men that is similar to the range of the published data (20). Some studies that were done in Iran have reported different results from our study. Omrani et al showed that the incidence of microdeletions among azoospermic patients in North West of Iran was 24.2%; Malekasgar et al indicated that the incidence of Yq microdeletions in South West of Iran was higher than international frequency. They found microdeletions in 52% (16, 21).
These variations in frequencies could be due to different origins of the studied population and differences in the study design including the composition of the study population and different STSs selection. Mirfakhraie et al showed that the incidence of microdeletion in Yq chromosome is 12% that this result is similar to ours (17). In table III we compared our results with other similar studies. With use of mentioned STSs we reported the most frequent microdeletions in AZFc, followed by AZFb and no deletion in AZFa and AZFd that is similar to many past studies such as Mirfakhraie et al who reported the most frequent microdeletions in AZFb region followed by AZFc.
Controversy in Y chromosomal microdeletions of infertile men arises from this fact that Yq microdeletions will be transmitted by ICSI and cause the infertility problem in sons. This possibility has been described previously (22). Screening of Yq microdeletions can help medical stuff to give informative counseling to couples with these deletions that want to use Because of this probability ethical consequences should be one of the important dimensions of these techniques.
Table III. Percentage of Yq microdeletion in different study
Conflict of interest
The authors declare that there is no conflidt of interest.
Type of Study: Original Article |
References
1. Balkan M, Tekes S, Gedik A. Cytogenetic and Y chromosome microdeletion screening studies in infertile males with oligozoospermia and azoospermia in southeast Turkey. J Assist Reprod Genet 2008; 25: 559-565. [DOI:10.1007/s10815-008-9272-8]
2. Nagvenkar P, Desai K, Hinduja I, Zaveri K. Chromosomal studies in infertile men with oligozoospermia & non-obstructive azoospermia. Indian J Med Res 2005; 122: 34-42.
3. Dada R, Gupta NP, Kucheria K. Molecular screening for Yq microdeletion in men with idiopathic oligozoospermia and azoospermia. J Bioscie 2003; 28: 163-168. [DOI:10.1007/BF02706215]
4. Skakkebaek NE, Giwercman A, de Kretser D. Pathogenesis and management of male infertility. Lancet 1994; 343: 1473-1479. [DOI:10.1016/S0140-6736(94)92586-0]
5. Vutyavanich T, Piromlertamorn W, Sirirungsi W, Sirisukkasem S. Frequency of Y chromosome microdeletions and chromosomal abnormalities in infertile Thai men with oligozoospermia and azoospermia. Asian J Androl 2007; 9: 68-75. [DOI:10.1111/j.1745-7262.2007.00239.x]
6. Krausz C, Quintana-Murci L, McElreavey K. Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis? Hum Reprod 2000; 15: 1431-1444. [DOI:10.1093/humrep/15.7.1431]
7. Kleiman SE, Yogev L, Gamzu R, Hauser R, Botchan A, Lessing JB, et al. Genetic evaluation of infertile men. Hum Reprod 1999; 14: 33-38. [DOI:10.1093/humrep/14.1.33]
8. Behulova R, Varga I, Strhakova L, Bozikova A, Gabrikova D, Boronova I, et al. Incidence of microdeletions in the AZF region of the Y chromosome in Slovak patients with azoospermia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011; 155: 33-38. [DOI:10.5507/bp.2011.006]
9. Vergnaud G, Page DC, Simmler MC, Brown L, Rouyer F, Noel B, et al. A deletion map of the hyman Y chromosome based on DNA hybridization. Am J Hum Genet 1986; 38 109-124.
10. Kent-First M, Muallem A, Shultz J, Pryor J, Roberts K, Nolten W, et al. Defining regions of the Y-chromosome responsible for male infertility and identification of a fourth AZF region (AZFd) by Y-chromosome microdeletion detection. Mol Reprod Dev 1999; 53: 27-41.
https://doi.org/10.1002/(SICI)1098-2795(199905)53:1<27::AID-MRD4>3.0.CO;2-W [DOI:10.1002/(SICI)1098-2795(199905)53:13.0.CO;2-W]
11. Sadeghi-Nejad H, Farrokhi F. Genetics of azoospermia: Current knowledge, clinical implications, and future directions. Urol J 2007; 4: 192-206.
12. Raicu F, Popa L, Apostol P, Cimponeriu D, Dan L, Ilinca E, et al. Screening for microdeletions in human Y chromosome-AZF candidate genes and male infertility. J Cell Mol Med 2003; 7: 43-48. [DOI:10.1111/j.1582-4934.2003.tb00201.x]
13. Page DC, Silber S, Brown LG. Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperminjection, but are likely to transmit the deletion and infertility. Hum Reprod 1999; 14: 1722-1726. [DOI:10.1093/humrep/14.7.1722]
14. Kuhnert B, Gromoll J, KostovaE, Tschanter P, Luetjens CM, SimoniM, et al. Case report: natural transmission of an AZFc Y-chromosomal microdeletion from father to his sons. Hum Reprod 2004; 19: 886-888. [DOI:10.1093/humrep/deh186]
15. Kamischke A, Gromoll J, Simoni M, Behre HM, Nieschlag E. Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperminjection: case report. Hum Reprod 1999; 14 : 2320-2322. [DOI:10.1093/humrep/14.9.2320]
16. Malekasgar AM, Mombaini H. Screening of 'Y' chromosome microdeletions in Iranian infertile males. J Hum Reprod Sci 2008; 1: 2-9. [DOI:10.4103/0974-1208.38973]
17. Mirfakhraie R, Mirzajani F, Kalantar SM, Montazeri M, Salsabili N, Pourmand GR, et al. High prevalence of AZFb microdeletion in Iranian patients with idiopathic non-obstructive azoospermia. Indian J Med Res 2010; 132: 265-270.
18. Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl 2004; 27: 240-249. [DOI:10.1111/j.1365-2605.2004.00495.x]
19. Poongothai J, Gopenath TS, Manonayaki S. Genetics of human male infertility. Singapore Med J 2009; 50: 336-347.
20. Omrani MD, Samadzadae S, Bagheri M, Attar K. Y Chromosome microdeletions in idiopathic infertile menfrom West Azarbaijan. Urol J 2006; 3: 38-43.
21. Silber SJ, Alagappan R, Brown LG, Page DC. Y chromosome deletions in azoospermic and severely oligozoospermic men undergoing intracytoplasmic sperm injection after testicular sperm extraction. Hum Reprod 1998; 13: 3332-3337. [DOI:10.1093/humrep/13.12.3332]
22. Miller SA, Dykes DD. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215. [DOI:10.1093/nar/16.3.1215]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
